IFNB1 and COVID-19: The production of IFN-β by perivascular macrophages and damaged endothelial cells in skin lesions of COVID-19 patients were demonstrated, alongside with elevated levels of IL-1, IL-6, and TNF-α, resulting in a disrupted type I IFN and pro-inflammatory cytokine response [31].